US2011098359A1PendingUtilityA1
Compositions and Methods for Treatment of Glaucoma
Est. expiryAug 7, 2027(~1 yrs left)· nominal 20-yr term from priority
Inventors:David R. Meyer
A61K 31/167A61P 27/02A61P 27/06
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A new use for paracetamol in a method of treating glaucoma, which method comprises administering to a patient in need of such treatment 500 mg to 1000 mg of paracetamol in oral format 4 to 6 hourly. An ophthalmic solution is also provided containing between 0.1 to 5% of paracetamol which is administered as one to two drops in each eye 4 to 6 hourly. The ophthalmic solution further includes one or more of the following excipients: hydroxypropylmethylcellulose, benzalconium chloride, polyacrylic acid such as Teargel®.
Claims
exact text as granted — not AI-modified1 . Paracetamol for use in a method of treating glaucoma, which method comprises administering to a patient in need of such treatment an effective amount of paracetamol.
2 . Paracetamol according to claim 1 wherein the effective amount of paracetamol is between 500 mg and 1000 mg.
3 . Paracetamol according to either claim 1 or 2 wherein the paracetamol is administered to the patient in an oral format.
4 . Paracetamol according to claim 1 wherein the paracetamol is administered to the patient in the form of an ophthalmic solution.
5 . Paracetamol according to claim 4 wherein the ophthalmic solution contains between 0.1 and 5% of paracetamol.
6 . Paracetamol according to either claim 4 or 5 wherein the paracetamol is administered as one to two drops of the solution to each eye 4 to 6 hourly.
7 . An ophthalmic solution including as its active ingredient paracetamol.
8 . An ophthalmic solution according to claim 7 wherein the paracetamol is present in the range of 0.1 to 5%.
9 . The use of paracetamol in the manufacture of a medicament for use in a method of treating glaucoma which method comprises administering to a patient in need of such treatment an effective amount of paracetamol.
10 . The use according to either claim 9 wherein the paracetamol is administered to the patient in an oral format.
11 . The use according to claim 10 wherein the paracetamol is administered to the patient in the form of an ophthalmic solution.
12 . The use according to claim 11 wherein the ophthalmic solution contains between 0.1 and 5% of paracetamol.
13 . The use according to either claim 12 wherein the paracetamol is administered as one to two drops of the solution to each eye 4 to 6 hourly.
14 . A method of treatment of glaucoma which includes administering to a patient in need thereof an effective amount of paracetamol.
15 . A method as claimed in claim 14 wherein the paracetamol is administered orally.
16 . A method as claimed in claim 14 wherein the paracetamol is administered ophthalmically.
17 . A package which includes at least one dose of paracetamol in an amount effective for the treatment of glaucoma and instructions for the use thereof in a treatment for glaucoma.
18 . A package as claimed in claim 17 wherein the at least one dose of paracetamol is suitable for oral administration.
19 . A package as claimed in claim 17 wherein the at least one dose of paracetamol is suitable for ophthalmic administration.Join the waitlist — get patent alerts
Track US2011098359A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.